-
1 Comment
Melexis NV is currently in a long term uptrend where the price is trading 3.0% above its 200 day moving average.
From a valuation standpoint, the stock is 46.5% cheaper than other stocks from the Technology sector with a price to sales ratio of 7.3.
Melexis NV's total revenue rose by 16.0% to $147M since the same quarter in the previous year.
Its net income has increased by 56.2% to $24M since the same quarter in the previous year.
Finally, its free cash flow fell by 2.9% to $30M since the same quarter in the previous year.
Based on the above factors, Melexis NV gets an overall score of 4/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | BE0165385973 |
Sector | Technology |
Industry | Semiconductors |
Market Cap | 2B |
---|---|
PE Ratio | 11.44 |
Target Price | None |
Dividend Yield | 9.9% |
Beta | 1.41 |
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides current, inductive position, latch and switch, magnetic position, speed, optical, pressure, temperature, tire monitoring sensors ICs, and time-of-flight ToF; embedded motor, fan and pump, smart LED, pre-driver, and transceivers ICs, such as LIN transceiver, CAN transceiver, and RFID transceivers; as well as embedded lighting. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MEX.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025